Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Lerentang is a leading pharmaceutical commercial enterprise in China, operating as a major joint venture between China National Pharmaceutical Group (Sinopharm) and the historic Lerentang Group. Headquartered in Shijiazhuang, Hebei Province, the company specializes in the wholesale distribution, retail, and logistics of pharmaceuticals, medical devices, and healthcare products. It maintains a dominant market position in Northern China, supported by an extensive supply chain network and advanced cold-chain logistics capabilities. The company provides integrated healthcare services, including hospital supply chain management and a large network of retail pharmacies. As a key subsidiary within the Sinopharm ecosystem, it serves as a vital link between global pharmaceutical manufacturers and the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopharm Lerentang.